About Collidion
Collidion is a Healthcare company based in Petaluma (United States) founded in 2015. Early-stage healthcare research is licensed for product development. Collidion has raised $14.53 million across 3 funding rounds. Collidion has completed 1 acquisition, including Plex Pharmaceuticals. Collidion offers products and services including Anti-infective Technologies, Pharmaceutical Innovations, and Consumer Health Products. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Diversified. Its legal entity is Collidion Inc. Its competitors include Avidity Biosciences, Sutro Biopharma and Vividion Therapeutics; 3 of its 3 listed competitors have raised funding.
Company details
Collidion Inc. was founded in 2015 and is headquartered in Petaluma, United States. Operations center on the healthcare sector, where early-stage ideas and research are identified and licensed for advancement into commercial products. Emphasis is given to combating antibiotic resistance, developing drugs against biofilms, and creating delivery systems for both systemic and topical applications.
- Headquarters Petaluma, United States
- SectorsHealthcare
- Email••••••••
- Website collidion.com
- Social LinkedIn
- Legal Name Collidion Inc.
- Total Equity Funding$14.53M (USD)
in 3 rounds
- Latest Funding Round$14.26M (USD), Series A
Oct 2019
- Investments & Acquisitions
Products & Services of Collidion
Collidion offers a comprehensive portfolio of products and services, including Anti-infective Technologies, Pharmaceutical Innovations, and Consumer Health Products.
Develops technologies for anti-infectives and disinfection to improve patient care.
Focuses on treatments for diseases like Parkinson's and cataracts.
Creates products for sterilization and consumer health applications.
Funding Insights of Collidion
Collidion has successfully raised a total of $14.53M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $14.26 million completed in October 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $14.53M
- Total Rounds 3
- Last Round Series A — $14.26M
All 3 funding rounds of Collidion with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2019 | $14.26M | Series A | – | – | – |
| Apr 2019 | Debt – Conventional | – | – | – | |
| Apr 2019 | $275,000 | Series A | – | – | – |
People of Collidion
18 people are tracked at Collidion (4 in leadership, 13 in board & advisors, 1 in team).
| Name | Role | Group |
|---|---|---|
Diana W. | Director of Marketing and Communications | Leadership |
Hoji Alimi | Founder, Chairman & CEO | Leadership |
Sameer Harish | Director of Finance | Leadership |
Bill Watson | Co-Founder & EVP of Business Development & Sales | Leadership |
Ettore Carino | Director | Board & advisors |
James Reznick | Advisor | Board & advisors |
Paul Auwaerter | Co-Chair | Board & advisors |
Greg French | Director | Board & advisors |
Jerry Stonemetz | Co-Chair | Board & advisors |
J. Brennan Cassidy | Advisor | Board & advisors |
David Marcus | Advisor | Board & advisors |
Alberto Gedissman | Advisor | Board & advisors |
David Allie | Advisor | Board & advisors |
Hugh Conway | Advisor | Board & advisors |
Kurt Piatkowski | Advisor | Board & advisors |
Jeffrey Castillo | Director | Board & advisors |
Ron Carli | Director | Board & advisors |
Diane C. Deturmeny | Business Development Coordinator | Team |
Complete people profiles for Collidion
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Collidion
Collidion has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Plex Pharmaceuticals.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Discovering small molecules for diseases caused by protein misfolding such as Parkinson's. | plexpharma.com | San Diego, United States | 2009 | Aug 2017 | •••• |
Complete acquisition details for Collidion
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Collidion
4 dated milestones of Collidion across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Collidion is founded.
- Acquisition Acquires Plex Pharmaceuticals.
- Funding First funding round.
- Funding Latest funding round, Series A, of $14.3M.
Competitors of Collidion
Collidion has 3 listed competitors in our database, 3 of them funded. They include Avidity Biosciences, Sutro Biopharma and Vividion Therapeutics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| vividion.com | 2016 | Oceanside, United States | $270.5M | 123 | Developing novel drugs based on a proteome-wide ligand and target discovery platform |
Detailed competitors of Collidion
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Collidion (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Collidion
Complete news archive for Collidion
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Collidion
Collidion was founded in 2015 and raised its 1st funding round 4 years after it was founded.
Collidion is headquartered in Petaluma, United States. It is registered at Petaluma, California, United States.
Collidion is a funded company, having raised a total of $14.53M across 3 funding rounds to date.
Collidion Inc. was founded in 2015 and is headquartered in Petaluma, United States. Operations center on the healthcare sector, where early-stage ideas and research are identified and licensed for advancement into commercial products. Emphasis is given to combating antibiotic resistance, developing drugs against biofilms, and creating delivery systems for both systemic and topical applications.
Collidion's top competitors include Sutro Biopharma, Avidity Biosciences and Vividion Therapeutics.
Collidion offers Anti-infective Technologies, Pharmaceutical Innovations, and Consumer Health Products.
Collidion has made 1 acquisition, including Plex Pharmaceuticals.
Collidion operates through Collidion Inc..